Form C/A — Oxeia Biopharmaceuticals, Inc.
0001610315-26-000005 · filed Jan 15, 2026
· via StartEngine Primary, LLC
https://oxeiabiopharma.com
(possible website — auto-inferred, not verified)
Offering
- Target
- $19,999
- Maximum
- $1,234,999
- Security type
- Other
- Price per security
- $0.7900
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 1610315
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 361 NEWBURY STREET
BOSTON, MA 02115 - Phone
- —
Most recent fiscal year financials
- Total assets
- $233,373
- Cash
- —
- Short-term debt
- $8,520,223
- Long-term debt
- $3,898,947
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-1,219,002
View the original filing on SEC EDGAR ↗